학술논문
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
Document Type
Article
Author
Source
In: Diabetes, Obesity and Metabolism . (Diabetes, Obesity and Metabolism, 1 March 2020, 22(3):442-451)
Subject
Language
English
ISSN
14631326
14628902
14628902